These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


529 related items for PubMed ID: 29422242

  • 1. Transjugular intrahepatic portosystemic shunt for hepatorenal syndrome: A systematic review and meta-analysis.
    Song T, Rössle M, He F, Liu F, Guo X, Qi X.
    Dig Liver Dis; 2018 Apr; 50(4):323-330. PubMed ID: 29422242
    [Abstract] [Full Text] [Related]

  • 2. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G, Ferro C, Sumberaz A, Messa P, Morelli N, Guadagni B, Ardizzone G, Valente U.
    Hepatogastroenterology; 2003 Apr; 50(54):1753-5. PubMed ID: 14696397
    [Abstract] [Full Text] [Related]

  • 3. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
    Will V, Rodrigues SG, Stirnimann G, Gottardi A, Bosch J, Berzigotti A.
    United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
    [Abstract] [Full Text] [Related]

  • 4. Transjugular intrahepatic portosystemic shunt in the management of ascites and hepatorenal syndrome.
    Senzolo M, Cholongitas E, Tibballs J, Burroughs A, Patch D.
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1143-50. PubMed ID: 17033432
    [Abstract] [Full Text] [Related]

  • 5. [The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension].
    Fang DC, Chen L.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):244-6. PubMed ID: 19403016
    [No Abstract] [Full Text] [Related]

  • 6. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.
    Krieger S, Jauss M, Jansen O, Stiehl A, Sauer P, Geissler M, Theilmann L, Krieger D.
    J Hepatol; 1997 Jul; 27(1):121-6. PubMed ID: 9252084
    [Abstract] [Full Text] [Related]

  • 7. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
    Bhatia Kapoor P, Benjamin J, Tripathi H, Patidar Y, Maiwall R, Kumar G, Joshi YK, Sarin SK.
    Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
    [Abstract] [Full Text] [Related]

  • 8. A prospective evaluation of changes in neuropsychological and liver function tests following transjugular intrahepatic portosystemic stent-shunt.
    Jalan R, Gooday R, O'Carroll RE, Redhead DN, Elton RA, Hayes PC.
    J Hepatol; 1995 Dec; 23(6):697-705. PubMed ID: 8750169
    [Abstract] [Full Text] [Related]

  • 9. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
    Guevara M, Ginès P, Bandi JC, Gilabert R, Sort P, Jiménez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodés J.
    Hepatology; 1998 Aug; 28(2):416-22. PubMed ID: 9696006
    [Abstract] [Full Text] [Related]

  • 10. Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study.
    Brensing KA, Textor J, Perz J, Schiedermaier P, Raab P, Strunk H, Klehr HU, Kramer HJ, Spengler U, Schild H, Sauerbruch T.
    Gut; 2000 Aug; 47(2):288-95. PubMed ID: 10896924
    [Abstract] [Full Text] [Related]

  • 11. Can pretransplant TIPS be harmful in liver transplantation? A propensity score matching analysis.
    Matsushima H, Fujiki M, Sasaki K, Cywinski JB, D'Amico G, Uso TD, Aucejo F, David Kwon CH, Eghtesad B, Miller C, Quintini C, Hashimoto K.
    Surgery; 2020 Jul; 168(1):33-39. PubMed ID: 32268937
    [Abstract] [Full Text] [Related]

  • 12. Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor?
    Khokhar MA, O'Beirne J.
    Dig Dis Sci; 2020 Nov; 65(11):3069-3071. PubMed ID: 32472258
    [No Abstract] [Full Text] [Related]

  • 13. Transjugular intrahepatic portosystemic stent-shunt for hepatorenal syndrome.
    Brensing KA, Textor J, Strunk H, Klehr HU, Schild H, Sauerbruch T.
    Lancet; 1997 Mar 08; 349(9053):697-8. PubMed ID: 9078203
    [No Abstract] [Full Text] [Related]

  • 14. Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients.
    Charilaou P, Devani K, Petrosyan R, Reddy C, Pyrsopoulos N.
    Dig Dis Sci; 2020 Nov 08; 65(11):3378-3388. PubMed ID: 32062714
    [Abstract] [Full Text] [Related]

  • 15. Improvement of hepatorenal syndrome by transjugular intrahepatic portosystemic shunt.
    Spahr L, Fenyves D, N'Guyen VV, Roy L, Legault L, Dufresne MP, Pomier-Layrargues G.
    Am J Gastroenterol; 1995 Jul 08; 90(7):1169-71. PubMed ID: 7611221
    [Abstract] [Full Text] [Related]

  • 16. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
    Armstrong MJ, Gohar F, Dhaliwal A, Nightingale P, Baker G, Greaves D, Mangat K, Zia Z, Karkhanis S, Olliff S, Mehrzad H, Steeds RP, Tripathi D.
    Aliment Pharmacol Ther; 2019 Mar 08; 49(6):797-806. PubMed ID: 30773660
    [Abstract] [Full Text] [Related]

  • 17. Prediction of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Based on CT Radiomic Features of Visceral Adipose Tissue.
    Cheng S, Hu G, Jin Z, Wang Z, Xue H.
    Acad Radiol; 2024 May 08; 31(5):1849-1861. PubMed ID: 38007366
    [Abstract] [Full Text] [Related]

  • 18. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update.
    Rössle M, Gerbes AL.
    Gut; 2010 Jul 08; 59(7):988-1000. PubMed ID: 20581246
    [Abstract] [Full Text] [Related]

  • 19. Severe acute alcoholic hepatitis and hepatorenal syndrome: role of transjugular intrahepatic portosystemic stent shunt.
    Testino G, Leone S, Ferro C, Borro P.
    J Med Life; 2012 Jun 12; 5(2):203-5. PubMed ID: 22802893
    [Abstract] [Full Text] [Related]

  • 20. Transjugular Intrahepatic Portosystemic Shunts: Advances and New Uses in Patients with Chronic Liver Disease.
    Boike JR, Flamm SL.
    Clin Liver Dis; 2020 Aug 12; 24(3):373-388. PubMed ID: 32620278
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 27.